Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.35
+0.74 (8.59%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.699.2913.5214.8510.29
Cash & Short-Term Investments
8.699.2913.5214.8510.29
Cash Growth
-6.49%-31.30%-8.95%44.36%6.62%
Other Receivables
0.470.743.368.532.99
Total Trade Receivables
0.470.743.368.532.99
Other Current Assets
1.511.272.273.661.72
Total Current Assets
10.6711.3119.1527.0515
Net Property, Plant & Equipment
33.9141.6957.2846.6538.07
Other Intangible Assets
10.2610.2610.2610.2610.26
Goodwill
3.493.493.493.493.49
Other Long-Term Assets
6.366.468.198.392.96
Total Assets
76.8886.4498.3695.8369.77
Accounts Payable
1.712.065.696.032.27
Accrued Expenses
2.192.280.771.831.04
Short-Term Debt
-38.95---
Current Portion of Leases
4.564.439.4817.011.51
Other Current Liabilities
0.490.530.52--
Total Current Liabilities
8.9548.2516.4624.874.81
Long-Term Debt
256.9255.4482.31--
Long-Term Leases
26.5327.6928.5831.836.48
Other Long-Term Liabilities
3.083.083.083.083.08
Total Long-Term Liabilities
286.5386.21113.9734.8839.56
Total Liabilities
295.48134.46130.4359.7544.37
Common Stock
0.360.360.360.360.27
Additional Paid-in Capital
282.57279.35276.39275.49227.98
Retained Earnings
-501.53-327.74-308.82-239.77-202.86
Shareholders' Equity
-218.6-48.02-32.0736.0825.4
Total Liabilities & Equity
76.8886.4498.3695.8369.77
Total Debt
288.02126.52120.3748.8237.99
Net Cash (Debt)
-279.33-117.22-106.85-33.96-27.7
Net Cash Per Share
-7.71-3.24-2.96-0.99-1.15
Book Value
-218.6-48.02-32.0736.0825.4
Book Value Per Share
-6.03-1.33-0.891.051.05
Tangible Book Value
-232.34-61.77-45.8122.3311.65
Tangible Book Value Per Share
-6.41-1.71-1.270.650.48
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q